All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| TNYA / Tenaya Therapeutics, Inc.
|
|
|
|
|
|
|
|
| EPIX / ESSA Pharma Inc.
|
|
|
|
|
|
|
|
| APYX / Apyx Medical Corporation
|
|
|
|
|
|
|
|
| CTMX / CytomX Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RARE / Ultragenyx Pharmaceutical Inc.
|
|
|
|
|
|
|
|
| XGN / Exagen Inc.
|
|
|
|
|
|
|
|
| GH / Guardant Health, Inc.
|
|
|
|
|
|
|
|
| STOK / Stoke Therapeutics, Inc.
|
|
|
|
|
|
|
|
| IMUX / Immunic, Inc.
|
|
|
|
|
|
|
|
| NTRA / Natera, Inc.
|
|
|
|
|
|
|
|
| DMTK / DermTech, Inc.
|
|
|
|
|
|
|
|
| TELA / TELA Bio, Inc.
|
|
|
|
|
|
|
|
| CYRX / Cryoport, Inc.
|
|
|
|
|
|
|
|
| UTRS / Minerva Surgical, Inc.
|
|
|
|
|
|
|
|
| CINC / CinCor Pharma Inc
|
|
|
|
|
|
|
|
| GLUE / Monte Rosa Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ARYE / ARYA Sciences Acquisition Corp V - Class A
|
|
|
|
|
|
|
|
| MSAC / Medicus Sciences Acquisition Corp - Class A
|
|
|
|
|
|
|
|
| MASS / 908 Devices Inc.
|
|
|
|
|
|
|
|
| RNA / Avidity Biosciences, Inc.
|
|
|
|
|
|
|
|
| RACB / Research Alliance Corp II - Class A
|
|
|
|
|
|
|
|
| FVAM / 5:01 Acquisition Corp.
|
|
|
|
|
|
|
|
| RGNX / REGENXBIO Inc.
|
|
|
|
|
|
|
|
| RCEL / AVITA Medical, Inc.
|
|
|
|
|
|
|
|
| ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| RCOR.WS / Renovacor, Inc. Warrants, enti Warrants, entitling the holder thereof to purchase one-half (1/2) of a share of common stock at a price of $11.50 per whole share
|
|
|
|
|
|
|
|
| LJPC / La Jolla Pharmaceutical Co.
|
|
|
|
|
|
|
|
| TNDM / Tandem Diabetes Care, Inc.
|
|
|
|
|
|
|
|
| ROIV / Roivant Sciences Ltd.
|
|
|
|
|
|
|
|
| DNAY / Codex DNA Inc
|
|
|
|
|
|
|
|
| ATHA / Athira Pharma, Inc.
|
|
|
|
|
|
|
|
| LUNG / Pulmonx Corporation
|
|
|
|
|
|
|
|
| MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
| / Cytek Biosciences, Inc.
|
|
|
|
|
|
|
|
| SUMMIT HEALTHCRE ACQUISTN CO
/ UNIT 06/03/2026 (G8566R128) |
|
|
|
|
|
|
|
| / VENTYX BIOSCIENCES INC
|
|
|
|
|
|
|
|
| QTRX / Quanterix Corporation
|
|
|
|
|
|
|
|
| KYG5960S1241 / Medicus Sciences Acquisition Corp.
|
|
|
|
|
|
|
|
| / Nautilus Biotechnology Inc
|
|
|
|
|
|
|
|
| OMIC / Singular Genomics Systems, Inc.
|
|
|
|
|
|
|
|
| ISO / IsoPlexis Corp
|
|
|
|
|
|
|
|
| PRCT / PROCEPT BioRobotics Corporation
|
|
|
|
|
|
|
|
| RXST / RxSight, Inc.
|
|
|
|
|
|
|
|
| MGNX / MacroGenics, Inc.
|
|
|
|
|
|
|
|
| CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| APLS / Apellis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| PRQR / ProQR Therapeutics N.V.
|
|
|
|
|
|
|
|
| SOPH / SOPHiA GENETICS SA
|
|
|
|
|
|
|
|
| NSTG / NanoString Technologies, Inc.
|
|
|
|
|
|
|
|
| ADVM / Adverum Biotechnologies, Inc.
|
|
|
|
|
|
|
|
| CDXS / Codexis, Inc.
|
|
|
|
|
|
|
|
| CSTL / Castle Biosciences, Inc.
|
|
|
|
|
|
|
|
| GHRS / GH Research PLC
|
|
|
|
|
|
|
|
| PNT / POINT Biopharma Global Inc.
|
|
|
|
|
|
|
|
| ALGN / Align Technology, Inc.
|
|
|
|
|
|
|
|
| URGN / UroGen Pharma Ltd.
|
|
|
|
|
|
|
|
| AXNX / Axonics, Inc.
|
|
|
|
|
|
|
|
| ILMN / Illumina, Inc.
|
|
|
|
|
|
|
|
| ZY / Zymergen Inc
|
|
|
|
|
|
|
|
| APEN / Apollo Endosurgery Inc
|
|
|
|
|
|
|
|
| BLSA / BCLS Acquisition Corp - Class A
|
|
|
|
|
|
|
|
| JNJ / Johnson & Johnson
|
|
|
|
|
|
|
|
| LSAQ / LifeSci Acquisition II Corp
|
|
|
|
|
|
|
|
| OYST / Oyster Point Pharma Inc
|
|
|
|
|
|
|
|
| ITOS / iTeos Therapeutics, Inc.
|
|
|
|
|
|
|
|
| GTH / Genetron Holdings Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| SLGC / Standard BioTools Inc.
|
|
|
|
|
|
|
|
| TSVT / 2seventy bio, Inc.
|
|
|
|
|
|
|
|
| MXCT / MaxCyte, Inc.
|
|
|
|
|
|
|
|
| VERU / Veru Inc.
|
|
|
|
|
|
|
|
| MIRO / Miromatrix Medical Inc
|
|
|
|
|
|
|
|
| ACET / Adicet Bio, Inc.
|
|
|
|
|
|
|
|
| CTIC / CTI BioPharma Corp
|
|
|
|
|
|
|
|
| CCCC / C4 Therapeutics, Inc.
|
|
|
|
|
|
|
|
| JNCE / Jounce Therapeutics Inc
|
|
|
|
|
|
|
|
| AGEN / Agenus Inc.
|
|
|
|
|
|
|
|
| NYXH / Nyxoah SA
|
|
|
|
|
|
|
|
| PYXS / Pyxis Oncology, Inc.
|
|
|
|
|
|
|
|
| ARYD / ARYA Sciences Acquisition Corp IV
|
|
|
|
|
|
|
|
| CLDX / Celldex Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SGHT / Sight Sciences, Inc.
|
|
|
|
|
|
|
|
| CHAQ / Chardan Healthcare Acquisition 2 Corp
|
|
|
|
|
|
|
|
| AADI / Aadi Bioscience, Inc.
|
|
|
|
|
|
|
|
| TMO / Thermo Fisher Scientific Inc.
|
|
|
|
|
|
|
|
| PMVP / PMV Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| PEN / Penumbra, Inc.
|
|
|
|
|
|
|
|
| LABP / Landos Biopharma, Inc.
|
|
|
|
|
|
|
|
| AVDL / Avadel Pharmaceuticals plc
|
|
|
|
|
|
|
|
| VCEL / Vericel Corporation
|
|
|
|
|
|
|
|
| RXDX / Prometheus Biosciences Inc
|
|
|
|
|
|
|
|
| AKYA / Akoya Biosciences, Inc.
|
|
|
|
|
|
|
|
| OM / Outset Medical, Inc.
|
|
|
|
|
|
|
|
| OLK / Olink Holding AB (publ) - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| IMTX / Immatics N.V.
|
|
|
|
|
|
|
|
| MIST / Milestone Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| GMED / Globus Medical, Inc.
|
|
|
|
|
|
|
|
| PTCT / PTC Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BWAY / BrainsWay Ltd. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| MASI / Masimo Corporation
|
|
|
|
|
|
|
|
| TARS / Tarsus Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| AXSM / Axsome Therapeutics, Inc.
|
|
|
|
|
|
|
|
| PTGX / Protagonist Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TWST / Twist Bioscience Corporation
|
|
|
|
|
|
|
|
| RLMD / Relmada Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| MLTX / MoonLake Immunotherapeutics
|
|
|
|
|
|
|
|
| TXG / 10x Genomics, Inc.
|
|
|
|
|
|
|
|
| ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
| FULC / Fulcrum Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ESTA / Establishment Labs Holdings Inc.
|
|
|
|
|
|
|
|
| RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CUTRQ / Cutera, Inc.
|
|
|
|
|
|
|
|
| IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
